Adjei AA - Search Results

1

Impact of pretreatment factors on adverse events: a pooled analysis of North Central Cancer Treatment Group advanced stage non-small cell lung cancer trials.

Mandrekar SJ, Northfelt DW, Schild SE, Foster NR, Bot B, Marks RS, Mailliard JA, Krook JE, Maksymiuk AW, Adjei AA, Jett JR. Mandrekar SJ, et al. Among authors: adjei aa. J Thorac Oncol. 2006 Jul;1(6):556-63. J Thorac Oncol. 2006. PMID: 17409917 Free article.

2

Current guidelines for the management of small cell lung cancer.

Adjei AA, Marks RS, Bonner JA. Adjei AA, et al. Mayo Clin Proc. 1999 Aug;74(8):809-16. doi: 10.4065/74.8.809. Mayo Clin Proc. 1999. PMID: 10473359 Review.

3

Docetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancer.

Adjei AA, Argiris A, Murren JR. Adjei AA, et al. Semin Oncol. 1999 Oct;26(5 Suppl 16):32-40; discussion 41-2. Semin Oncol. 1999. PMID: 10585007 Review.

4

Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity.

Adjei AA, Klein CE, Kastrissios H, Goldberg RM, Alberts SR, Pitot HC, Sloan JA, Reid JM, Hanson LJ, Atherton P, Rubin J, Erlichman C. Adjei AA, et al. J Clin Oncol. 2000 Mar;18(5):1116-23. doi: 10.1200/JCO.2000.18.5.1116. J Clin Oncol. 2000. PMID: 10694565 Clinical Trial.

5

Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors.

Adjei AA, Erlichman C, Sloan JA, Reid JM, Pitot HC, Goldberg RM, Peethambaram P, Atherton P, Hanson LJ, Alberts SR, Jett J. Adjei AA, et al. J Clin Oncol. 2000 Apr;18(8):1748-57. doi: 10.1200/JCO.2000.18.8.1748. J Clin Oncol. 2000. PMID: 10764436 Clinical Trial.

6

A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity.

Adjei AA, Erlichman C, Davis JN, Cutler DL, Sloan JA, Marks RS, Hanson LJ, Svingen PA, Atherton P, Bishop WR, Kirschmeier P, Kaufmann SH. Adjei AA, et al. Cancer Res. 2000 Apr 1;60(7):1871-7. Cancer Res. 2000. PMID: 10766174 Clinical Trial.

7

Management of small cell cancer of the lung.

Adjei AA. Adjei AA. Curr Opin Pulm Med. 2000 Jul;6(4):384-90. doi: 10.1097/00063198-200007000-00022. Curr Opin Pulm Med. 2000. PMID: 10912650 Review.

8

A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors.

Pitot HC, Reid JM, Sloan JA, Ames MM, Adjei AA, Rubin J, Bagniewski PG, Atherton P, Rayson D, Goldberg RM, Erlichman C. Pitot HC, et al. Among authors: adjei aa. Clin Cancer Res. 2002 Mar;8(3):712-7. Clin Cancer Res. 2002. PMID: 11895900 Clinical Trial.

9

Novel targets for lung cancer therapy: part II.

Dy GK, Adjei AA. Dy GK, et al. Among authors: adjei aa. J Clin Oncol. 2002 Jul 1;20(13):3016-28. doi: 10.1200/JCO.2002.02.112. J Clin Oncol. 2002. PMID: 12089232 Review.

10

Advances in systemic therapy of small cell cancer of the lung.

Daniels GA, Adjei AA. Daniels GA, et al. Among authors: adjei aa. Expert Rev Anticancer Ther. 2001 Aug;1(2):211-21. doi: 10.1586/14737140.1.2.211. Expert Rev Anticancer Ther. 2001. PMID: 12113026 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

461 results

Search Page

Filters